RHeference
  • Allele
    • List
    • Search
  • References
    • All
    • By Author
    • By Journal
  • Documentation
  • Statistics
  • Search
    • By name
    • By mutation
    • In exons
    • Complex
  • Contact

Article

Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women. Stegmann TC, Veldhuisen B, Bijman R, Thurik FF, Bossers B, Cheroutre G, Jonkers R, Ligthart P, de Haas M, Haer-Wigman L, van der Schoot CE. Br J Haematol, 2016. [Citation]

Annotations by Allele

  • apparently standard RHD with unexpected serology: RH1 (adsorption-elution was performed)
  • apparently standard RHD with unexpected serology: Prevalence
  • RHD deletion (RHD*01N.01): RH1
  • RHD deletion - partly characterized: Prevalence
  • RHD*1073+1T (IVS7+1T, RHD*01N.70): RH1 (adsorption-elution was performed)
  • RHD*1073+1T (IVS7+1T, RHD*01N.70): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*1073+1T (IVS7+1T, RHD*01N.70): Prevalence
  • RHD*1074-1A (IVS7-1A, RHD*01N.71): RH1 (adsorption-elution was performed)
  • RHD*1074-1A (IVS7-1A, RHD*01N.71): otherHaplotype ("linked RHCE genotype" for 3 samples, complete phenotype not given)
  • RHD*1074-1A (IVS7-1A, RHD*01N.71): Prevalence
  • RHD*1084T (Q362*, RHD*01N.64): RH1 (adsorption-elution was performed)
  • RHD*1084T (Q362*, RHD*01N.64): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*1084T (Q362*, RHD*01N.64): Prevalence
  • RHD*1154C (weak D type 2): RH1 (initially typed as D negative)
  • RHD*1154C (weak D type 2): Serology (Table II)
  • RHD*1154C (weak D type 2): Prevalence
  • RHD*1154C (weak D type 2): RH1 (used as control for transfection assay of ddccee erythroblasts)
  • RHD*1174delA (RHD*01N.66): Prevalence
  • RHD*1174delA (RHD*01N.66): RH1 (adsorption-elution was performed)
  • RHD*1174delA (RHD*01N.66): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*1203A (Y401*, RHD*01N.22, DEL17): RH1 (adsorption-elution was performed)
  • RHD*1203A (Y401*, RHD*01N.22, DEL17): Prevalence
  • RHD*1224C (weak D type 22): RH1
  • RHD*1224C (weak D type 22): RH1 (initially typed as D negative)
  • RHD*1224C (weak D type 22): Prevalence
  • RHD*1227A (DEL1): RH1 (adsorption-elution was performed)
  • RHD*1227A (DEL1): Prevalence
  • RHD*124_125delAA (RHD*01N.65): RH1 (adsorption-elution was performed)
  • RHD*124_125delAA (RHD*01N.65): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*124_125delAA (RHD*01N.65): Prevalence
  • RHD*1252_1253insT (*418L, DEL11): RH1 (adsorption-elution was performed)
  • RHD*1252_1253insT (*418L, DEL11): Prevalence
  • RHD*148+1A (IVS1+1A, DEL5): RH1 (adsorption-elution was performed)
  • RHD*148+1A (IVS1+1A, DEL5): Prevalence
  • RHD*178C,689T (RHD*60): Prevalence
  • RHD*178C,689T (RHD*60): RH1 (heterozygous with RHef00011)
  • RHD*178C,689T (RHD*60): Serology (Table II)
  • RHD*178C,689T (RHD*60): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*209A,998A,1136T (DAU2): RH1
  • RHD*209A,998A,1136T (DAU2): Prevalence
  • RHD*335T (01N.68): Prevalence
  • RHD*335T (01N.68): RH1 (adsorption-elution was performed)
  • RHD*335T (01N.68): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*424delATG (M142del, RHD*01N.74): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*424delATG (M142del, RHD*01N.74): Prevalence
  • RHD*424delATG (M142del, RHD*01N.74): RH1 (adsorption-elution was performed, phenotype confirmed by transfection of ddccee erythroblasts)
  • RHD*424delATG (M142del, RHD*01N.74): Serology (Table II)
  • RHD*443G (RHD*01N.73): RH1 (adsorption-elution was performed, phenotype confirmed by transfection of ddccee erythroblasts)
  • RHD*443G (RHD*01N.73): Serology (Table II)
  • RHD*443G (RHD*01N.73): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*443G (RHD*01N.73): Prevalence
  • RHD*446A (weak D type 5): RH1
  • RHD*446A (weak D type 5): RH1 (initially typed as D negative)
  • RHD*446A (weak D type 5): Prevalence
  • RHD*486+1A (IVS3+1A, DEL8): RH1 (adsorption-elution was performed)
  • RHD*486+1A (IVS3+1A, DEL8): Prevalence
  • RHD*486+2A (IVS3+2A, DEL9): RH1 (adsorption-elution was performed)
  • RHD*486+2A (IVS3+2A, DEL9): Prevalence
  • RHD*492A (RHD*61): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*492A (RHD*61): Prevalence
  • RHD*492A (RHD*61): RH1 (phenotype confirmed by transfection of ddccee erythroblasts)
  • RHD*492A (RHD*61): Serology (Table II)
  • RHD*602G,667G,819A,919A: Prevalence
  • RHD*602G,667G,819A,919A: RH1 (adsorption-elution was performed)
  • RHD*634+1T,1136T (DAU, RHD*01N.69): RH1 (adsorption-elution was performed)
  • RHD*634+1T,1136T (DAU, RHD*01N.69): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*634+1T,1136T (DAU, RHD*01N.69): Prevalence
  • RHD*660delG or RHD*659delG (RHD*01N.29, RHD*01N.78): RH1 (adsorption-elution was performed)
  • RHD*660delG or RHD*659delG (RHD*01N.29, RHD*01N.78): Prevalence
  • RHD*689T,1136T (DAU1): RH1 (heterozygous with RHef00129)
  • RHD*689T,1136T (DAU1): Serology (Table II)
  • RHD*689T,1136T (DAU1): Prevalence
  • RHD*721C (DEL45): otherHaplotype ("linked RHCE genotype" for 7 samples, complete phenotype not given)
  • RHD*721C (DEL45): Prevalence
  • RHD*721C (DEL45): RH1 (adsorption-elution was performed, phenotype confirmed by transfection of ddccee erythroblasts)
  • RHD*721C (DEL45): Serology (Table II)
  • RHD*809G (weak D type 1): RH1
  • RHD*809G (weak D type 1): RH1 (initially typed as D negative)
  • RHD*809G (weak D type 1): Prevalence
  • RHD*833A (weak D type 38): RH1 (initially typed as D negative)
  • RHD*833A (weak D type 38): Prevalence
  • RHD*833A (weak D type 38): RH1
  • RHD*845A (weak partial D type 15): RH1
  • RHD*845A (weak partial D type 15): Prevalence
  • RHD*884C (weak D type 94, DEL46): RH1 (adsorption-elution was performed)
  • RHD*884C (weak D type 94, DEL46): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*884C (weak D type 94, DEL46): Prevalence
  • RHD*885T (weak partial D type 11): RH1
  • RHD*885T (weak partial D type 11): Prevalence
  • RHD*922T (G308*, RHD*01N.52, DEL15): RH1 (adsorption-elution was performed)
  • RHD*922T (G308*, RHD*01N.52, DEL15): Prevalence
  • RHD*93insT (RHD*01N.50, DEL18): RH1 (adsorption-elution was performed)
  • RHD*93insT (RHD*01N.50, DEL18): Prevalence
  • RHD*952T (R318*, RHD*01N.61): RH1 (adsorption-elution was performed)
  • RHD*952T (R318*, RHD*01N.61): Prevalence
  • RHD*D-CE(2-9)-D (RHD*01N.03, RHD*01N.04): RH1
  • RHD*D-CE(2-9)-D (RHD*01N.03, RHD*01N.04): Prevalence
  • RHD*D-CE(3)-weak D type 4.0 (RHD*01N.72): Prevalence
  • RHD*D-CE(3)-weak D type 4.0 (RHD*01N.72): RH1 (adsorption-elution was performed)
  • RHD*D-CE(3)-weak D type 4.0 (RHD*01N.72): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHD*D-CE(4)-D (DFR2, RHD*17.02): RH1
  • RHD*D-CE(4)-D (DFR2, RHD*17.02): Prevalence
  • RHD*D-cE(4-5)-D (DVI type 1): Prevalence
  • RHD*D-cE(4-5)-D (DVI type 1): RH1
  • RHD*D-CE(4-6)-D (DVI type 2): RH1
  • RHD*D-CE(4-6)-D (DVI type 2): Prevalence
  • RHD*D-CE(5:667-5:787)-D (DV type 7, DAL): RH1
  • RHD*D-CE(5:667-5:787)-D (DV type 7, DAL): Prevalence
  • RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): RH1
  • RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): Prevalence
  • RHD*Dpsi (RHD*08N.01): RH1
  • RHD*Dpsi (RHD*08N.01): Prevalence
  • RHD*Ex1del (RHD*01N.67): Prevalence
  • RHD*Ex1del (RHD*01N.67): RH1 (adsorption-elution was performed)
  • RHD*Ex1del (RHD*01N.67): otherHaplotype ("linked RHCE genotype" for 1 sample, complete phenotype not given)
  • RHDex10del - partly characterized: RH1 (adsorption-elution was performed)
  • RHDex10del - partly characterized: Prevalence
  • standard RHD (RHD*01): RH1 (used as control for transfection assay of ddccee erythroblasts)
  • standard RHD (RHD*01): Serology (Table II)